Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126772532 | 12677253 | 2 | F | 20160801 | 20160901 | 20160823 | 20160909 | EXP | AU-JNJFOC-20160804669 | JANSSEN | 80.62 | YR | E | M | Y | 72.00000 | KG | 20160909 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126772532 | 12677253 | 1 | PS | DARATUMUMAB | DARATUMUMAB | 1 | Intravenous (not otherwise specified) | Y | N | 761036 | 1156 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | ||||||
| 126772532 | 12677253 | 2 | SS | DARATUMUMAB | DARATUMUMAB | 1 | Intravenous (not otherwise specified) | Y | N | 100638 | CONCENTRATE FOR SOLUTION FOR INFUSION | ||||||||
| 126772532 | 12677253 | 3 | SS | LENALIDOMIDE | LENALIDOMIDE | 1 | Oral | 0 | CAPSULE | ||||||||||
| 126772532 | 12677253 | 4 | SS | LENALIDOMIDE | LENALIDOMIDE | 1 | Oral | 0 | CAPSULE | ||||||||||
| 126772532 | 12677253 | 5 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126772532 | 12677253 | 6 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126772532 | 12677253 | 7 | C | LOVAN | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 0 | 20 | MG | TABLET | ||||||||
| 126772532 | 12677253 | 8 | C | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 0 | 4 | MG | INJECTION | ||||||||
| 126772532 | 12677253 | 9 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 40 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126772532 | 12677253 | 1 | Plasma cell myeloma |
| 126772532 | 12677253 | 2 | Plasma cell myeloma |
| 126772532 | 12677253 | 3 | Plasma cell myeloma |
| 126772532 | 12677253 | 4 | Plasma cell myeloma |
| 126772532 | 12677253 | 5 | Plasma cell myeloma |
| 126772532 | 12677253 | 6 | Plasma cell myeloma |
| 126772532 | 12677253 | 7 | Depression |
| 126772532 | 12677253 | 8 | Plasma cell myeloma |
| 126772532 | 12677253 | 9 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126772532 | 12677253 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126772532 | 12677253 | Empyema | |
| 126772532 | 12677253 | Pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126772532 | 12677253 | 1 | 20160805 | 0 | ||
| 126772532 | 12677253 | 8 | 20121022 | 0 | ||
| 126772532 | 12677253 | 9 | 20150226 | 0 |